Cellectis' headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq ...

Cross-species BBB-penetrant IV-delivered AAV gene therapy provides broad and robust CNS tau lowering in tauopathy mouse ...

Edesa Biotech, Inc. , a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, announced today that the company will participate in ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

The National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final ...

The Amano Enzyme team will be co-chairing and presenting in two separate sessions in the AOCS Technical Program, covering the ...

UT researchers have created an alternative to Edman degradation for protein sequencing using bases instead of acid ...

Siren said proceeds will go toward investigational new drug (IND)-enabling animal studies and clinical-grade production of ...

Using their novel Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D bioprinting technique, which allows for the ...

Ex-Google CEO Eric Schmidt warns AI could surpass human control by 2026. Discover the risks and opportunities of artificial ...

Researchers document a multi-faceted global snapshot of the environmental aspects and trends surrounding single-use plastics in a review article. The researchers state that the largest area of ...